Is ATNM or AUPH more undervalued in 2026?

CirclFi compares Actinium Pharmaceuticals, Inc. (ATNM) and Aurinia Pharmaceuticals Inc (AUPH) using 13 institutional-grade valuation models. ATNM has a Quality of Company score of 5.3/10 while AUPH scores 9.9/10.

Which is a better buy — ATNM or AUPH?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ATNM and AUPH valuations compare?

ATNM at $1.15 and AUPH at $15.35 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ATNM vs AUPH Valuation Comparison 2026 — Intrinsic Value Analysis

ATNM

Biotechnology

Actinium Pharmaceuticals, Inc.

Quality

5.3

out of 10

Value Trap

LOW

Price

$1.15

Last close

Models

9/13

Active

AUPH

Biotechnology

Aurinia Pharmaceuticals Inc

Quality

9.9

out of 10

Value Trap

SAFE

Price

$15.35

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	ATNM Fair Value	ATNM Upside	AUPH Fair Value	AUPH Upside
Bayesian DCF	Intrinsic	$0.95	-17.1%	$15.99	+4.1%
Earnings Power Value	Intrinsic	—	—	$6.74	-56.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$0.63	-46.5%	$13.47	-12.3%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ATNM vs AUPH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ATNM vs AUPH — Which Stock Is More Undervalued?

AUPH scores higher with a 9.9/10 quality rating vs ATNM's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Actinium Pharmaceuticals, Inc. (ATNM) and Aurinia Pharmaceuticals Inc (AUPH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ATNM currently trades at $1.15 with a QOC of 5.3/10, while AUPH trades at $15.35 with a QOC of 9.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).